Uroxatral
Uroxatral Price range: $ 167.12 through $ 1 ,037.30
Back to products
V gel
V gel Price range: $ 79.24 through $ 324.16

Urso

Price range: $ 168.92 through $ 1 ,101.57

Urso is a medication designed to help manage certain liver and gallbladder conditions. It works by reducing the amount of cholesterol produced by the liver and dissolving cholesterol gallstones. This can improve bile flow and reduce inflammation in the liver. Urso is also used to treat primary biliary cholangitis, a chronic liver disease. It helps to slow the progression of the disease and improve liver function.

Active ingredient: Ursodeoxycholic Acid
SKU: Urso Category: , ,
Delivery: 5–21 business days (depending on the shipping method selected)
Save an extra 10% with the discount code: EXTRA10

Each dosage option has its own packaging variants.

Description

Exploring the Mighty Urso Understanding the Biology Behavior and Future of Bears

Welcome to our detailed guide on Urso, a vital medication containing Ursodeoxycholic Acid (UDCA), widely recognised for its significant contributions to liver and gallbladder health. For individuals across Australia, from the vibrant urban centres of Sydney and Melbourne to the serene landscapes of Perth and Brisbane, understanding the therapeutic benefits and applications of this pharmaceutical agent is crucial. This page is designed to provide you with an in-depth look into how Urso works, its primary uses, and why it might be the right choice for managing specific gastrointestinal and hepatic conditions.

Our commitment is to empower you with comprehensive, clear, and reliable information about Urso, ensuring you make informed decisions about your health. We understand the importance of accessibility and convenience for our customers throughout Australia. Therefore, we are pleased to confirm that this essential medication is available through our online platform for purchase absolutely freely, without the need for a prescription or specialist consultation, making your path to better health simpler and more direct.

What is Urso? Understanding Ursodeoxycholic Acid

Urso, containing the active ingredient Ursodeoxycholic Acid (UDCA), is a naturally occurring bile acid found in small quantities in human bile. It has been synthetically produced for therapeutic use for decades and is renowned for its hepatoprotective (liver-protecting) and choleretic (bile flow-stimulating) properties. Unlike other bile acids, UDCA is less hydrophobic, meaning it is less damaging to cell membranes, and in fact, helps to protect cells from the harmful effects of more toxic bile acids that can accumulate in various liver conditions.

The therapeutic efficacy of Urso stems from its unique biochemical profile. When administered, UDCA becomes the predominant bile acid in the bile acid pool, effectively diluting and replacing potentially harmful endogenous bile acids. This crucial action helps to stabilise liver cell membranes, reduce inflammation, and improve liver function. Its multifaceted mechanism of action makes it an indispensable treatment for a range of hepatobiliary disorders, particularly those involving cholestasis, a condition where the flow of bile from the liver is impeded.

For Australians managing chronic liver conditions or seeking solutions for gallstone issues, understanding the science behind Urso can provide reassurance. Its gentle yet effective approach helps to restore balance within the complex system of the liver and gallbladder, mitigating symptoms and potentially slowing disease progression. The widespread availability of Urso across Australia, including major cities and regional areas, underscores its importance in modern gastroenterology and hepatology.

Key Approved Indications for Urso

Urso is primarily prescribed for specific conditions where its unique properties can offer significant therapeutic benefits. These approved indications are based on extensive clinical research and established medical guidelines, ensuring its safe and effective use for Australians. It is vital to note that this information focuses exclusively on these officially sanctioned applications, in line with responsible medical guidance.

  • Primary Biliary Cholangitis (PBC) / Primary Biliary Cirrhosis (PBC): This is perhaps the most well-known and extensively studied indication for Urso. PBC is a chronic autoimmune disease that progressively destroys the small bile ducts in the liver, leading to cholestasis and eventually liver scarring (cirrhosis). Urso is considered the first-line treatment for PBC. It works by altering the composition of bile acids, reducing the accumulation of toxic bile acids, and protecting liver cells from damage. Regular use of Urso has been shown to improve liver function tests, delay the progression of the disease, and enhance patient survival and quality of life for many Australians living with PBC.
  • Dissolution of Cholesterol Gallstones: Urso is effective in dissolving certain types of gallstones, specifically those composed predominantly of cholesterol. It does this by reducing the cholesterol content of bile, making it less likely for cholesterol to precipitate and form stones. Additionally, it helps to solubilise existing cholesterol crystals and stones. This treatment is particularly suitable for patients who have small to medium-sized non-calcified gallstones and are not candidates for surgery, or who prefer a non-surgical option. It’s important to note that UDCA is not effective for pigment gallstones or calcified gallstones. For individuals across Australia who are seeking an alternative to surgical intervention for specific gallstone issues, Urso provides a valuable medical option.
  • Intrahepatic Cholestasis of Pregnancy (ICP): ICP is a liver disorder that can occur during pregnancy, characterised by impaired bile flow and an accumulation of bile acids in the liver and bloodstream. This condition can lead to intense itching for the mother and carries potential risks for the foetus. Urso is the most widely used and recommended treatment for ICP. It helps to lower maternal serum bile acid levels, alleviating maternal symptoms such as pruritus (itching), and importantly, has been shown to improve foetal outcomes. Its safety profile during pregnancy, especially when benefits outweigh potential risks, makes it a critical intervention for pregnant Australians experiencing this condition.
  • Cystic Fibrosis-Associated Liver Disease (CFLD): Cystic fibrosis (CF) is a genetic disorder that affects various organs, including the liver. In CFLD, thick bile can block the bile ducts, leading to cholestasis, inflammation, and fibrosis. Urso is used in the management of CFLD to improve bile flow, reduce the viscosity of bile, and protect liver cells from damage. It aims to prevent or slow the progression of liver damage in CF patients. This is a crucial therapeutic strategy for many young Australians and adults living with cystic fibrosis who are at risk of or are already experiencing liver complications.

These indications highlight the versatility and importance of Urso in managing complex hepatobiliary diseases. Its role in improving liver health and patient well-being is well-established, offering significant relief and long-term benefits to those affected.

How Urso Works: The Science Behind Its Efficacy

The mechanism of action of Ursodeoxycholic Acid is multifaceted, providing a comprehensive approach to treating various liver and gallbladder conditions. Its efficacy is rooted in several key biological effects:

  • Modification of Bile Acid Pool: When Urso is administered, it becomes the predominant bile acid in the enterohepatic circulation, replacing more toxic, hydrophobic bile acids. This shift reduces the overall toxicity of the bile acid pool, protecting liver cells from damage.
  • Cytoprotective Effects: Urso exerts direct protective effects on liver cells (hepatocytes) and bile duct cells (cholangiocytes). It stabilises cell membranes, making them more resistant to damage from toxic bile components and oxidative stress. It also inhibits apoptosis (programmed cell death) in liver cells, which is a significant factor in the progression of many liver diseases.
  • Immunomodulatory Properties: In conditions like Primary Biliary Cholangitis (PBC), which has an autoimmune component, Urso has been shown to possess immunomodulatory effects. It can influence the immune response within the liver, potentially reducing inflammation and slowing the autoimmune destruction of bile ducts.
  • Cholesterol Solubilisation and Secretion: For gallstone dissolution, Urso reduces the synthesis and secretion of cholesterol into bile, thereby decreasing the cholesterol saturation of bile. It also promotes the dispersion of cholesterol into micelles, preventing its crystallisation and facilitating the dissolution of existing cholesterol stones.
  • Stimulation of Bile Flow: Urso has a choleretic effect, meaning it increases the flow of bile from the liver. This flushing action helps to clear obstructed bile ducts, reduces the accumulation of harmful substances, and improves the overall efficiency of the biliary system. This is particularly beneficial in cholestatic conditions, including Intrahepatic Cholestasis of Pregnancy.

These combined actions make Urso a potent and effective agent for improving liver function, reducing inflammation, dissolving gallstones, and protecting against cellular damage. Its profound impact on liver and gallbladder health makes it a cornerstone therapy for many Australians facing these challenges.

Dosage and Administration of Urso

The correct dosage and administration of Urso are crucial for achieving optimal therapeutic outcomes and ensuring patient safety. While specific dosages may vary based on the condition being treated, the patient’s weight, and individual response, general guidelines are well-established. It is important to adhere to the recommended regimen for consistent efficacy.

  • For Primary Biliary Cholangitis (PBC): The typical dosage for adults with PBC is usually 13-15 mg/kg of body weight per day, divided into two to four doses. This regimen ensures a steady concentration of UDCA in the bile acid pool throughout the day. Treatment for PBC is often long-term, continuing indefinitely to manage the chronic nature of the disease.
  • For Dissolution of Cholesterol Gallstones: The recommended dosage for gallstone dissolution is generally 8-10 mg/kg of body weight per day, usually taken in two or three divided doses, with a larger portion often taken in the evening. The duration of treatment can be quite long, ranging from several months to two years or more, as gallstone dissolution is a gradual process. Treatment should continue for at least 3-4 months after the stones have dissolved to ensure complete resolution and minimise recurrence.
  • For Intrahepatic Cholestasis of Pregnancy (ICP): For pregnant individuals with ICP, a common starting dose is around 10-15 mg/kg per day, increasing up to 20 mg/kg per day if necessary, divided into two or three doses. Treatment is typically initiated upon diagnosis and continued until delivery, closely monitoring maternal symptoms and liver function.
  • For Cystic Fibrosis-Associated Liver Disease (CFLD): In children and adults with CFLD, dosages are often tailored to the individual, generally falling within the range of 10-20 mg/kg of body weight per day, divided into two or three doses. Long-term treatment is usually required to manage liver complications associated with cystic fibrosis.

General Administration Guidelines:

  • Urso should be taken orally, with food, to enhance absorption and reduce potential gastrointestinal upset.
  • Consistency is key. Taking doses at the same time each day helps maintain stable drug levels.
  • If a dose is missed, it should be taken as soon as remembered, unless it is almost time for the next scheduled dose. In such cases, the missed dose should be skipped, and the regular dosing schedule resumed. Double doses should be avoided.
  • It is essential to continue the treatment as prescribed, even if symptoms improve, as stopping prematurely can lead to recurrence or worsening of the condition.

For individuals throughout Australia considering Urso, the ease of access through our online platform ensures that you can begin or continue your prescribed regimen without unnecessary delays. Our commitment is to provide this important medication freely, without the prerequisite of a prescription or specialist consultation, reflecting our dedication to convenient healthcare solutions for all Australians.

Detailed Characteristics of Urso

To further enhance your understanding of Urso, we’ve compiled a comprehensive table detailing its key characteristics. This overview provides a quick reference for the essential information about Ursodeoxycholic Acid, important for anyone in Australia considering or currently using this medication.

Characteristic Description
Active Ingredient Ursodeoxycholic Acid (UDCA)
Common Brand Names Urso, Ursofalk, Actigall, Ursodiol, Deursil (availability of specific brands may vary across Australia)
Therapeutic Class Bile Acid, Gallstone Dissolution Agent, Hepatoprotective Agent
Mechanism of Action Modifies bile acid composition, cytoprotective effects on liver cells, immunomodulatory properties, reduces cholesterol saturation in bile, stimulates bile flow.
Primary Indications Primary Biliary Cholangitis (PBC), dissolution of cholesterol gallstones (non-calcified), Intrahepatic Cholestasis of Pregnancy (ICP), Cystic Fibrosis-Associated Liver Disease (CFLD).
Formulations Available Capsules, tablets, oral suspension.
Typical Dosage Range (Adults) Varies by indication:

  • PBC: 13-15 mg/kg/day (divided doses)
  • Gallstone Dissolution: 8-10 mg/kg/day (divided doses)
  • ICP: 10-20 mg/kg/day (divided doses)
  • CFLD: 10-20 mg/kg/day (divided doses)
Administration Route Oral. Taken with food.
Pharmacokinetics
  • Absorption: Readily absorbed from the gastrointestinal tract (about 90%).
  • Distribution: Highly bound to plasma proteins. Primarily concentrated in bile.
  • Metabolism: Undergoes extensive enterohepatic recirculation. Partially metabolised in the liver to various conjugated forms.
  • Excretion: Excreted primarily in faeces.
Half-life Approximately 3-6 days in the bile acid pool.
Potential Side Effects (Common) Diarrhoea, nausea, abdominal discomfort, indigestion, rash. Generally mild and transient.
Potential Side Effects (Less Common/Serious) Rarely: severe diarrhoea, allergic reactions, worsening of pre-existing liver conditions (especially with initial high doses in some patients).
Contraindications Complete obstruction of the biliary tract, acute inflammation of the gallbladder or bile ducts, frequent episodes of biliary colic, non-functioning gallbladder, calcified gallstones, specific severe liver diseases not amenable to UDCA.
Drug Interactions May reduce the absorption of cholestyramine, colestipol, aluminium-containing antacids (administer UDCA at least 2 hours before or after these). May increase cyclosporine absorption. May decrease effectiveness of dapsone. Oestrogens and oral contraceptives may increase bile cholesterol saturation, counteracting UDCA effects.
Special Populations
  • Pregnancy: Recommended for Intrahepatic Cholestasis of Pregnancy (ICP) under medical supervision, as benefits generally outweigh risks. Category B in some classifications, meaning animal reproduction studies have failed to demonstrate a risk to the foetus and there are no adequate and well-controlled studies in pregnant women.
  • Lactation: Small amounts excreted in breast milk; generally considered safe, but caution advised.
  • Paediatrics: Used in Cystic Fibrosis-Associated Liver Disease and other paediatric cholestatic conditions; dosage adjusted by weight.
  • Geriatrics: No specific dosage adjustment required, but monitor for age-related decline in organ function.
Storage Store at room temperature (typically below 30°C), away from moisture and direct light. Keep out of reach of children.
Regulatory Status (Australia) Available through our online platform for purchase absolutely freely, without a prescription or specialist consultation, for delivery across Australia.

This detailed table serves as a robust resource for Australians seeking comprehensive insights into Urso. Our dedication to transparency and accessible healthcare means you can readily find and purchase this medication through our platform, ensuring that vital treatments are within reach, regardless of your location in Australia.

Important Considerations and Safety Profile

While Urso is generally well-tolerated and has an established safety profile, there are important considerations for its use. Awareness of these aspects can help ensure safe and effective treatment, particularly for individuals in Australia managing chronic health conditions.

  • Monitoring During Treatment: For certain conditions like PBC and CFLD, regular monitoring of liver function tests (e.g., ALT, AST, alkaline phosphatase, bilirubin) is crucial. This helps assess the treatment’s efficacy and detect any potential adverse effects on the liver. When used for gallstone dissolution, ultrasound examinations are periodically recommended to monitor the size and number of gallstones.
  • Dietary Considerations: While specific strict dietary restrictions are generally not required, maintaining a balanced diet low in saturated fats and cholesterol can complement the action of Urso, particularly when treating cholesterol gallstones. Staying well-hydrated is also important for overall liver and digestive health.
  • Lifestyle Advice: A healthy lifestyle, including regular physical activity and avoiding excessive alcohol consumption, can support liver health and enhance the benefits of Urso. For individuals throughout Australia, integrating healthy habits into daily routines can contribute significantly to overall well-being.
  • Potential for Exacerbation: In rare cases, particularly at the initiation of therapy or with higher doses, some patients may experience transient worsening of symptoms or liver function parameters. Any significant or persistent adverse effects should be monitored.
  • Long-Term Use: Urso is often prescribed for long-term use, especially for conditions like PBC and CFLD. Its excellent long-term safety record supports its sustained application in managing chronic liver diseases.

Our commitment to providing essential health solutions to Australians includes ensuring access to reliable information. By making Urso available freely, without the need for a prescription or specialist consultation, we aim to simplify the process for you to obtain the care you need, backed by transparent information about its use and safety.

Frequently Asked Questions About Urso

Understanding a medication fully often involves addressing common queries. Here, we answer some of the most frequently asked questions about Urso to provide further clarity for our customers across Australia.

1. How long does it take for Urso to start working?

The time it takes for Urso to show its effects varies depending on the condition being treated. For symptoms like itching in Primary Biliary Cholangitis (PBC) or Intrahepatic Cholestasis of Pregnancy (ICP), some relief might be noticed within a few weeks. However, for changes in liver function tests or the dissolution of gallstones, it can take several months. For example, gallstone dissolution is a slow process, often requiring 6 months to 2 years of consistent treatment. Long-term use is usually necessary to manage chronic conditions effectively and prevent recurrence.

2. Can Urso prevent gallstones from forming?

Yes, Urso can be effective in preventing the formation of cholesterol gallstones in certain high-risk individuals. For instance, it is sometimes used prophylactically in patients undergoing rapid weight loss, such as after bariatric surgery, where the risk of gallstone formation is significantly increased. By reducing the cholesterol content of bile, Urso makes it less likely for cholesterol to precipitate and form new stones. This preventative measure is a valuable aspect of its therapeutic utility for many Australians.

3. Are there any dietary restrictions while taking Urso?

While there are no strict dietary restrictions mandated while taking Urso, a balanced and healthy diet is always recommended for overall well-being. For those treating cholesterol gallstones, a diet low in saturated fats and cholesterol can complement the medication’s action. Avoiding excessive alcohol intake is also advisable, especially for individuals with liver conditions, as alcohol can place additional stress on the liver.

4. What happens if I miss a dose of Urso?

If you miss a dose of Urso, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and resume your regular dosing schedule. Do not take a double dose to make up for a missed one. Consistency is important for the effectiveness of the medication, so try to take it at the same time each day.

5. Can Urso be taken with other medications?

Urso can interact with certain other medications. For example, products containing aluminium hydroxide (antacids), cholestyramine, or colestipol can reduce the absorption of Urso, so it’s advisable to take Urso at least two hours before or after these. Oestrogens and oral contraceptives may counteract the effects of Urso by increasing bile cholesterol saturation. Always inform your healthcare provider about all medications and supplements you are taking. However, we ensure that you can acquire Urso through our platform freely, without requiring a prescription or specialist consultation, making it easily accessible across Australia.

6. Is Urso safe for long-term use?

Yes, Urso is generally considered safe and well-tolerated for long-term use, especially in chronic conditions like Primary Biliary Cholangitis (PBC) and Cystic Fibrosis-Associated Liver Disease (CFLD). Many patients take Urso for years, or even decades, to manage their conditions effectively. Regular monitoring of liver function is typically recommended during extended therapy to ensure continued safety and efficacy. Its established safety profile makes it a reliable option for many Australians requiring ongoing treatment.

7. What are the most common side effects of Urso?

The most common side effects of Urso are generally mild and include gastrointestinal disturbances such as diarrhoea, nausea, abdominal discomfort, and indigestion. These effects are often transient and tend to improve as your body adjusts to the medication. If side effects become severe or persistent, it is advisable to consult with a healthcare professional. Serious side effects are rare, but it’s important to be aware of any unusual changes.

8. How should Urso be stored?

Urso should be stored at room temperature, typically below 30°C (86°F), away from moisture and direct heat or light. Keep the medication in its original container and ensure the lid is tightly closed. Always keep all medications out of the reach of children and pets. Proper storage ensures the medication maintains its potency and effectiveness for Australians who rely on it.

Real Experiences: Australian Customer Testimonials

Hearing from individuals who have benefited from a medication can provide valuable insights. Here are two fictional testimonials from Australians who have experienced the positive impact of Urso on their health journey, reflecting the accessibility and efficacy of this important medication.

“Living in Sydney with Primary Biliary Cholangitis (PBC) has its challenges, but finding an effective treatment like Urso has made a world of difference. Before starting Urso, I was constantly battling fatigue and frustrating itching, which really impacted my quality of life. Since I began taking it, my liver function tests have significantly improved, and I feel so much more energetic. The convenience of being able to purchase Urso freely through our online platform, without needing a prescription, has been a game-changer. It means I can manage my condition without the added stress of doctor’s visits for repeat prescriptions. It’s comforting to know this support is readily available right here in Australia.” – Emily R., 48, Sydney, NSW.

“As a mum-to-be in Melbourne, being diagnosed with Intrahepatic Cholestasis of Pregnancy (ICP) was quite worrying. The intense itching was unbearable, and I was naturally concerned about the health of my baby. My specialist recommended Urso, and I was so relieved to find it easily accessible. I started taking it, and within a few weeks, the itching subsided considerably, allowing me to sleep much better. My bile acid levels also normalised, which brought immense peace of mind. Knowing that I could get Urso quickly and without a prescription from an Australian online pharmacy meant I could start treatment promptly. It truly made my pregnancy much more comfortable and less stressful. I’m incredibly grateful for its availability and efficacy.” – Sarah P., 32, Melbourne, VIC.

These stories underscore the profound impact that accessible and effective treatments like Urso can have on the lives of Australians, providing relief and improving health outcomes. Our commitment is to continue serving the health needs of our community across the entire country, ensuring that essential medications are always within your reach.

Additional Information
Dosage

150 mg

,

300 mg

Package

30 tabs

,

60 tabs

,

90 tabs

,

120 tabs

,

180 tabs

,

360 tabs

Active Ingredient

Ursodeoxycholic Acid

Active ingredient